SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-10-063621
Filing Date
2010-12-21
Accepted
2010-12-21 07:00:27
Documents
7
Period of Report
2010-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a10-23010_18k.htm 8-K 64928
2 EX-5.1 a10-23010_1ex5d1.htm EX-5.1 7062
3 EX-10.1 a10-23010_1ex10d1.htm EX-10.1 537196
4 EX-10.2 a10-23010_1ex10d2.htm EX-10.2 42901
5 EX-99.1 a10-23010_1ex99d1.htm EX-99.1 12138
6 GRAPHIC g230101kki001.jpg GRAPHIC 2129
7 GRAPHIC g230101mmi001.gif GRAPHIC 5046
  Complete submission text file 0001104659-10-063621.txt   676428
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062862501
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 101264236
SIC: 2834 Pharmaceutical Preparations